M&T Bank Corp Has $2.38 Million Position in Certara, Inc. (NASDAQ:CERT)

M&T Bank Corp cut its stake in shares of Certara, Inc. (NASDAQ:CERT) by 4.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 135,007 shares of the company’s stock after selling 6,361 shares during the quarter. M&T Bank Corp owned approximately 0.08% of Certara worth $2,375,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. William Blair Investment Management LLC lifted its holdings in shares of Certara by 1.1% during the third quarter. William Blair Investment Management LLC now owns 7,150,914 shares of the company’s stock valued at $103,974,000 after acquiring an additional 77,805 shares during the period. Massachusetts Financial Services Co. MA increased its position in Certara by 33.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,110,074 shares of the company’s stock worth $30,680,000 after purchasing an additional 530,695 shares during the period. Bamco Inc. NY increased its position in Certara by 15.1% in the third quarter. Bamco Inc. NY now owns 1,069,103 shares of the company’s stock worth $15,545,000 after purchasing an additional 140,000 shares during the period. Rathbones Group PLC acquired a new stake in Certara in the third quarter worth about $11,007,000. Finally, Kayne Anderson Rudnick Investment Management LLC increased its position in Certara by 48.8% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 727,240 shares of the company’s stock worth $10,574,000 after purchasing an additional 238,603 shares during the period. 73.96% of the stock is owned by institutional investors.

Certara Stock Performance

Shares of CERT opened at $16.35 on Thursday. The firm’s 50 day moving average price is $17.72 and its two-hundred day moving average price is $16.44. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62. Certara, Inc. has a twelve month low of $11.81 and a twelve month high of $22.65. The firm has a market cap of $2.62 billion, a P/E ratio of -46.71, a PEG ratio of 1.81 and a beta of 1.61.

Certara (NASDAQ:CERT) last posted its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). The company had revenue of $88.01 million during the quarter, compared to the consensus estimate of $86.80 million. Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. On average, analysts forecast that Certara, Inc. will post 0.29 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Barclays lifted their price objective on Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. JMP Securities assumed coverage on Certara in a research report on Thursday, April 4th. They issued a “market perform” rating for the company. UBS Group boosted their target price on Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research report on Friday, March 1st. Leerink Partnrs reiterated a “market perform” rating on shares of Certara in a research report on Monday, February 26th. Finally, Jefferies Financial Group boosted their price objective on shares of Certara from $14.00 to $15.50 and gave the company a “hold” rating in a report on Friday, March 1st. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Certara presently has a consensus rating of “Hold” and an average target price of $20.06.

Insider Transactions at Certara

In related news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the sale, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, SVP Richard M. Traynor sold 6,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $18.00, for a total value of $108,000.00. Following the completion of the transaction, the senior vice president now owns 165,368 shares in the company, valued at approximately $2,976,624. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares in the company, valued at approximately $3,123,432. The disclosure for this sale can be found here. Insiders sold 23,427 shares of company stock valued at $405,095 over the last three months. Company insiders own 2.39% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.